171 related articles for article (PubMed ID: 33853556)
1. Apolipoprotein A1 is negatively associated with male papillary thyroid cancer patients: a cross-sectional study of single academic center in China.
Ma M; Wang M; Zhang Z; Lin B; Sun Z; Guan H; Lv W; Li J
BMC Endocr Disord; 2021 Apr; 21(1):69. PubMed ID: 33853556
[TBL] [Abstract][Full Text] [Related]
2. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
Li CL; Dionigi G; Zhao YS; Liang N; Sun H
J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin.
Buczyńska A; Kościuszko M; Sidorkiewicz I; Wiatr AA; Adamska A; Siewko K; Dzięcioł J; Szelachowska M; Krętowski AJ; Popławska-Kita A
J Clin Endocrinol Metab; 2024 Jun; 109(7):1866-1872. PubMed ID: 38181425
[TBL] [Abstract][Full Text] [Related]
4. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
5. Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
Shi Y; Su C; Hu H; Yan H; Li W; Chen G; Xu D; Du X; Zhang P
PLoS One; 2018; 13(6):e0198896. PubMed ID: 29949618
[TBL] [Abstract][Full Text] [Related]
6. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
7. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
[TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinemia and thyroid peroxidase antibody in Chinese patients with papillary thyroid cancer.
Guo X; Chen X; Zhang C; Zhang J; Zhang C
Endocr J; 2019 Aug; 66(8):731-737. PubMed ID: 31118347
[TBL] [Abstract][Full Text] [Related]
9. Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma.
Wang Y; Zhou S; Wang D; Wei T; Zhu J; Li Z
Front Endocrinol (Lausanne); 2021; 12():737638. PubMed ID: 34803909
[TBL] [Abstract][Full Text] [Related]
10. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance.
Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY
Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393
[TBL] [Abstract][Full Text] [Related]
11. Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population: A retrospective case-control study.
Zhao S; Jia X; Fan X; Zhao L; Pang P; Wang Y; Luo Y; Wang F; Yang G; Wang X; Gu W; Zang L; Pei Y; Du J; Ba J; Dou J; Mu Y; Lyu Z
Medicine (Baltimore); 2019 Dec; 98(50):e18213. PubMed ID: 31852078
[TBL] [Abstract][Full Text] [Related]
12. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism.
Zabłocka-Słowińska K; Płaczkowska S; Skórska K; Prescha A; Pawełczyk K; Porębska I; Kosacka M; Grajeta H
PLoS One; 2019; 14(4):e0215246. PubMed ID: 30973911
[TBL] [Abstract][Full Text] [Related]
14. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
[No Abstract] [Full Text] [Related]
15. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
Rezaei M; Khamaneh AM; Zarghami N; Vosoughi A; Hashemzadeh S
BMC Cancer; 2019 Jul; 19(1):690. PubMed ID: 31307429
[TBL] [Abstract][Full Text] [Related]
16. The Clinicopathological Features of Papillary Thyroid Carcinoma Patients with Positive Hepatitis B Surface Antigen.
Zhong Z; Yuan J; Chen X; Chen Z; Du J; Chen Z; Kuang J; Cong S; Li J; Wu Z
Oncol Res Treat; 2020; 43(1-2):27-33. PubMed ID: 31722345
[TBL] [Abstract][Full Text] [Related]
17. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Fanaei SA; Hedayati M; Azizi F
BMC Cancer; 2018 Dec; 18(1):1199. PubMed ID: 30509240
[TBL] [Abstract][Full Text] [Related]
18. Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics.
Preda C; Branisteanu D; Armasu I; Danila R; Velicescu C; Ciobanu D; Covic A; Grigorovici A
BMC Surg; 2019 Jul; 19(1):94. PubMed ID: 31311533
[TBL] [Abstract][Full Text] [Related]
19. Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study.
Jeong C; Kwon HI; Baek H; Kim HS; Lim DJ; Baek KH; Ha J; Kang MI
Endocrinol Metab (Seoul); 2020 Dec; 35(4):925-932. PubMed ID: 33297604
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of circulating microRNAs in the diagnosis of papillary thyroid carcinoma.
Liu Y; Geng H; Liu X; Cao M; Zhang X
PLoS One; 2021; 16(5):e0251676. PubMed ID: 34019567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
